Gyre Therapeutics (GYRE) Operating Income Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -50.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.43% |
| Dec 31, 2025 | 28.13% |
| Sep 30, 2025 | 49.49% |
| Jun 30, 2025 | -65.20% |
| Mar 31, 2025 | 29.16% |
| Dec 31, 2024 | 26.68% |
| Sep 30, 2024 | 29.42% |
| Jun 30, 2024 | 29.27% |
| Mar 31, 2024 | 33.13% |
| Dec 31, 2023 | -69.43% |
| Sep 30, 2023 | 40.82% |
| Jun 30, 2023 | 31.74% |
| Mar 31, 2023 | 49.10% |
| Dec 31, 2022 | -17.10% |
| Sep 30, 2022 | 26.84% |
| Jun 30, 2022 | 77.40% |
| Mar 31, 2022 | 2.20% |
| Dec 31, 2021 | -20.24% |
| Sep 30, 2021 | -44.60% |
| Jun 30, 2021 | -40.93% |
| Mar 31, 2021 | -49.77% |
| Dec 31, 2020 | -47.86% |
| Sep 30, 2020 | -39.92% |
| Jun 30, 2020 | -42.94% |
| Mar 31, 2020 | -6.71% |
| Dec 31, 2019 | -38.89% |
| Sep 30, 2019 | -32.19% |
| Jun 30, 2019 | -43.03% |
| Mar 31, 2019 | -50.91% |
| Dec 31, 2018 | -35.63% |
| Sep 30, 2018 | -29.03% |
| Jun 30, 2018 | -47.85% |
| Mar 31, 2018 | -30.12% |
| Dec 31, 2017 | -48.00% |
| Sep 30, 2017 | -53.10% |
| Jun 30, 2017 | -39.07% |
| Mar 31, 2017 | -30.82% |
| Dec 31, 2016 | 26.80% |
| Sep 30, 2016 | 24.26% |
| Jun 30, 2016 | 26.72% |
| Mar 31, 2016 | 17.94% |
| Dec 31, 2015 | 33.96% |
| Sep 30, 2015 | 21.72% |
| Jun 30, 2015 | -29.16% |
| Mar 31, 2015 | -52.21% |
| Dec 31, 2014 | 43.83% |
| Sep 30, 2014 | 44.01% |
| Jun 30, 2014 | 4.92% |
| Mar 31, 2014 | -29.10% |
| Dec 31, 2013 | -114.05% |
| Sep 30, 2013 | -95.21% |
| Jun 30, 2013 | -65.28% |